Trials / Completed
CompletedNCT02478060
Birch-SPIRE Safety and Efficacy Study
A Double-Blind, Randomised, Placebo-Controlled, Escalating, Multiple Dose Study in to Assess the Safety, Tolerability and Pharmacodynamic Effects of Birch-SPIRE
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Circassia Limited · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of multiple administrations of Birch-SPIRE. To make a preliminary assessment on pharmacodynamic parameters and clinical outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Birch-SPIRE | |
| BIOLOGICAL | Placebo |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-07-01
- First posted
- 2015-06-23
- Last updated
- 2016-11-08
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02478060. Inclusion in this directory is not an endorsement.